These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 21615212)
1. From cell biology to therapy: ENMD-2076 in the treatment of multiple myeloma. Zhang S; Farag SS Expert Opin Investig Drugs; 2011 Jul; 20(7):1015-28. PubMed ID: 21615212 [TBL] [Abstract][Full Text] [Related]
2. Preclinical activity of a novel multiple tyrosine kinase and aurora kinase inhibitor, ENMD-2076, against multiple myeloma. Wang X; Sinn AL; Pollok K; Sandusky G; Zhang S; Chen L; Liang J; Crean CD; Suvannasankha A; Abonour R; Sidor C; Bray MR; Farag SS Br J Haematol; 2010 Aug; 150(3):313-25. PubMed ID: 20560971 [TBL] [Abstract][Full Text] [Related]
3. ENMD-2076 for hematological malignancies. How J; Yee K Expert Opin Investig Drugs; 2012 May; 21(5):717-32. PubMed ID: 22397360 [TBL] [Abstract][Full Text] [Related]
4. The potential role of PD0332991 (Palbociclib) in the treatment of multiple myeloma. Altenburg JD; Farag SS Expert Opin Investig Drugs; 2015 Feb; 24(2):261-71. PubMed ID: 25494820 [TBL] [Abstract][Full Text] [Related]
5. Panobinostat for the treatment of multiple myeloma. Neri P; Bahlis NJ; Lonial S Expert Opin Investig Drugs; 2012 May; 21(5):733-47. PubMed ID: 22404247 [TBL] [Abstract][Full Text] [Related]
6. ENMD-2076, an oral inhibitor of angiogenic and proliferation kinases, has activity in recurrent, platinum resistant ovarian cancer. Matulonis UA; Lee J; Lasonde B; Tew WP; Yehwalashet A; Matei D; Behbakht K; Grothusen J; Fleming G; Lee NK; Arnott J; Bray MR; Fletcher G; Brokx RD; Castonguay V; Mackay H; Sidor CF; Oza AM Eur J Cancer; 2013 Jan; 49(1):121-31. PubMed ID: 22921155 [TBL] [Abstract][Full Text] [Related]
14. Thalidomide and lenalidomide in the treatment of multiple myeloma. Kumar S; Rajkumar SV Eur J Cancer; 2006 Jul; 42(11):1612-22. PubMed ID: 16750621 [TBL] [Abstract][Full Text] [Related]
15. New drugs for myeloma. Richardson PG; Mitsiades C; Schlossman R; Munshi N; Anderson K Oncologist; 2007 Jun; 12(6):664-89. PubMed ID: 17602058 [TBL] [Abstract][Full Text] [Related]
16. Bortezomib in multiple myeloma. Mateos MV; San Miguel JF Best Pract Res Clin Haematol; 2007 Dec; 20(4):701-15. PubMed ID: 18070714 [TBL] [Abstract][Full Text] [Related]